Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TSPO | P30536 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24676218 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24676210 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL19652786 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24676185 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24676407 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL19653549 | 0.99 | L3MBTL1 (0.41) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL23862257 | 0.99 | L3MBTL1 (0.41) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL24676261 | 0.98 | KDM4E (0.37) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL18777243 | 0.98 | ATM (0.42) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL18777274 | 0.96 | NR3C1 (0.34) | KDM4EATML3MBTL1TSPONR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230033529-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| US-20220238815-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230033529-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | LEF1, L1CAM, RAP1A | KDM4E 3096/4885ATM 2806/4885L3MBTL1 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.